TGF-beta1 is associated with the progression of intracranial deep white matter lesions: a pilot study with 5 years of magnetic resonance imaging follow-up

Intracranial deep white matter lesions (DWLs) are associated with chronic kidney disease (CKD) and cognitive impairment: A 5-year follow-up magnetic resonance imaging (MRI) study

(2011) N. Kuriyama et al.   ARCHIVES OF GERONTOLOGY AND GERIATRICS

Protection from Obesity and Diabetes by Blockade of TGF-β/Smad3 Signaling

(2011) Hariom Yadav et al.   Cell Metabolism

Medical Therapy of Aortic Aneurysms: A Pathophysiology-Based Approach

(2011) Giovanna Muscogiuri et al.   Current Vascular Pharmacology

Unravelling the Genetics of Ischaemic Stroke

(2010) Hugh S. Markus   PLOS MEDICINE

Predictive Markers of Blood Cytokine and Chemokine in Recurrent Brain Infarction

(2009) Nagato Kuriyama et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

A combination of PPAR-γ agonists and HMG CoA reductase inhibitors (statins) as a new therapy for the conservative treatment of AAS (aortic aneurysm syndromes)

(2009) Gian Pio Sorice et al.   MEDICAL HYPOTHESES

Association of HTRA1 Mutations and Familial Ischemic Cerebral Small-Vessel Disease

(2009) Kenju Hara et al.   NEW ENGLAND JOURNAL OF MEDICINE

Role of transforming growth factor-β superfamily signaling pathways in human disease

(2008) Kelly J. Gordon et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

TGF-β signaling in vascular biology and dysfunction

(2008) Marie-José Goumans et al.   CELL RESEARCH

Progression of White Matter Hyperintensities and Incidence of New Lacunes Over a 3-Year Period

(2008) Alida A. Gouw et al.   STROKE